Effect of mindfulness-based stress reduction program on psychological symptoms, quality of life, and symptom severity in patients with somatic symptom disorder

Zargar, Fatemeh; Rahafrouz, Leila; Tarrahi, Mohammad Javad

Effect of mindfulness-based stress reduction program on psychological symptoms, quality of life, and symptom severity in patients with somatic symptom disorder

Authors

¹ Department of Health Psychology, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

³ Department of Biostatistics and Epidemiology, Faculty of Health, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Patients with somatic symptom disorder (SSD) had a poor quality of life and suffered from depression, anxiety, and stress. Mindfulness-based stress reduction (MBSR) is a psychological treatment with remarkable effects on several psychological disorders. This study aimed to evaluate the effect of the MBSR program on psychological symptoms, quality of life, and symptom severity in patients with SSD. Materials and Methods: The patients with SSD were randomly divided into two groups of receiving venlafaxine alone and venlafaxine with an 8-week MBSR program. Depression, anxiety, and stress with their severities were assessed along with the quality of life, the number of physical symptoms and their severities, as well as SSD severity before and after the intervention. Subsequently, the results were compared between the two groups. Results: This study included 37 patients with SSD who referred to Shariati Psychosomatic Clinic, Isfahan, Iran, with a mean age of 37.08 ± 8.26 years. It should be noted that 37.8% of the participants were male. The intervention group obtained significantly lower scores in depression, anxiety, stress, and their severities, compared to the control group. Moreover, the number of physical symptoms, their severity, and the severity of SSD were significantly decreased more in the intervention group rather than the controls. Conclusion: The MBSR accompanied by prescribing venlafaxine can significantly reduce the severity of SSD, as well as the number and severity of physical symptoms. Moreover, it can reduce depression, anxiety, stress, and their severity. The MBSR can be used as complementary medicine for the treatment of patients with SSD.

Keywords

References

1.	Katz J, Rosenbloom BN, Fashler S. Chronic pain, psychopathology, and DSM-5 somatic symptom disorder. Can J Psychiatry 2015;60:160-7.
2.	Kurlansik SL, Maffei MS. Somatic symptom disorder. Am Fam Physician 2016;93:49-54.
3.	Fjorback LO, Carstensen T, Arendt M, Ornbøl E, Walach H, Rehfeld E, et al. Mindfulness therapy for somatization disorder and functional somatic syndromes: Analysis of economic consequences alongside a randomized trial. J Psychosom Res 2013;74:41-8.
4.	Burton C, McGorm K, Weller D, Sharpe M. Depression and anxiety in patients repeatedly referred to secondary care with medically unexplained symptoms: A case-control study. Psychol Med 2011;41:555-63.
5.	van Westrienen PE, Pisters MF, Veenhof C, de Wit NJ. Identification of patients with moderate medically unexplained physical symptoms in primary care with a five years follow-up. BMC Fam Pract 2019;20:66.
6.	van der Feltz-Cornelis CM, Hoedeman R, Keuter EJ, Swinkels JA. Presentation of the Multidisciplinary Guideline Medically Unexplained Physical Symptoms (MUPS) and somatoform disorder in the Netherlands: Disease management according to risk profiles. J Psychosom Res 2012;72:168-9.
7.	Campo JV. Annual research review: Functional somatic symptoms and associated anxiety and depression-developmental psychopathology in pediatric practice. J Child Psychol Psychiatry 2012;53:575-92.
8.	Romera I, Fernández-Pérez S, Montejo AL, Caballero F, Caballero L, Arbesú JÁ et al. Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: Prevalence of painful somatic symptoms, functioning and health status. J Affect Disord 2010;127:160-8.
9.	American Psychiatric Association. Diagnostic and statistical manual of mental disorders. BMC Med 2013;17:133-7.
10.	Norton PJ, Paulus DJ. Toward a unified treatment for emotional disorders: Update on the science and practice. Behav Ther 2016;47:854-68.
11.	Bekhuis E, Boschloo L, Rosmalen JG, Schoevers RA. Differential associations of specific depressive and anxiety disorders with somatic symptoms. J Psychosom Res 2015;78:116-22.
12.	McDougall W. An Outline of Abnormal Psychology, 1^st Edition. Philadelphia: Routledge; 2015.
13.	Koelen JA, Houtveen JH, Abbass A, Luyten P, Eurelings-Bontekoe EH, Van Broeckhuysen-Kloth SA, et al. Effectiveness of psychotherapy for severe somatoform disorder: Meta-analysis. Br J Psychiatry 2014;204:12-9.
14.	Nyklícek I, Kuijpers KF. Effects of mindfulness-based stress reduction intervention on psychological well-being and quality of life: Is increased mindfulness indeed the mechanism? Ann Behav Med 2008;35:331-40.
15.	De Vibe MF, Bjørndal A, Fattah S, Dyrdal GM, Halland E, Tanner-Smith EE. Mindfulness-based stress reduction (MBSR) for improving health, quality of life and social functioning in adults: A systematic review and meta-analysis. Campbell systematic reviews. 2017;13 (1):1-264.
16.	Dalili Z, Bayazi MH. The effectiveness of mindfulness-based cognitive therapy on the illness perception and psychological symptoms in patients with rheumatoid arthritis. Complement Ther Clin Pract 2019;34:139-44.
17.	Pleman B, Park M, Han X, Price LL, Bannuru RR, Harvey WF, et al. Mindfulness is associated with psychological health and moderates the impact of fibromyalgia. Clin Rheumatol 2019;38:1737-45.
18.	Lengacher CA, Reich RR, Post-White J, Moscoso M, Shelton MM, Barta M, et al. Mindfulness based stress reduction in post-treatment breast cancer patients: An examination of symptoms and symptom clusters. J Behav Med 2012;35:86-94.
19.	Veehof MM, Trompetter HR, Bohlmeijer ET, Schreurs KM. Acceptance-and mindfulness-based interventions for the treatment of chronic pain: A meta-analytic review. Cogn Behav Ther 2016;45:5-31.
20.	Kolahkaj B, Zargar F, Majdinasab N. The effect of mindfulness-based stress reduction (MBSR) Therapy on quality of life in women with multiple sclerosis, Ahvaz, Iran. J Caring Sci 2019;8:213-7.
21.	Grossman P, Kappos L, Gensicke H, D'Souza M, Mohr DC, Penner IK, et al. MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial. Neurology 2010;75:1141-9.
22.	van Ravesteijn HJ, Suijkerbuijk YB, Langbroek JA, Muskens E, Lucassen PL, van Weel C, et al. Mindfulness-based cognitive therapy (MBCT) for patients with medically unexplained symptoms: Process of change. J Psychosom Res 2014;77:27-33.
23.	van Ravesteijn H, Grutters J, olde Hartman T, Lucassen P, Bor H, van Weel C, et al. Mindfulness-based cognitive therapy for patients with medically unexplained symptoms: A cost-effectiveness study. J Psychosom Res 2013;74:197-205.
24.	Asghari A, Saed F, Dibajnia P. Psychometric properties of the Depression Anxiety Stress Scales-21 (DASS-21) in a non-clinical Iranian sample. Int J Psychol 2008;2:82-102.
25.	Motamed N, Ayatollahi AR, Zare N, Sadeghi-Hassanabadi A. Validity and reliability of the Persian translation of the SF-36 version 2 questionnaire. East Mediterr Health J 2005;11:349-57.
26.	Rezayat F, Dehgannayeri N. Relationship between depression and self-efficacy in nursing students. Iran J Nurs 2013;26:54-63.
27.	Norouzi M, Zargar F, Norouzi F. Effectiveness of acceptance and commitment therapy on interpersonal problems and difficulties in emotion regulation among university students. Iran J Psychiatry Behav Sci 2017;11:e8005.
28.	Wong SY. Effect of mindfulness-based stress reduction programme on pain and quality of life in chronic pain patients: A randomised controlled clinical trial. Hong Kong Med J 2009;15 Suppl 6:13-4.
29.	Lazar S. Change in brainstem gray matter concentration following a mindfulness-based intervention is correlated with improvement in psychological well-being. Front Hum Neurosci 2014;8:33.
30.	Esch T. The neurobiology of meditation and mindfulness. Meditation-Neuroscientific Approaches and Philosophical Implications. New York: Springer; 2014. p. 153-73.
31.	Fox KC, Nijeboer S, Dixon ML, Floman JL, Ellamil M, Rumak SP, et al. Is meditation associated with altered brain structure? A systematic review and meta-analysis of morphometric neuroimaging in meditation practitioners. Neurosci Biobehav Rev 2014;43:48-73.
32.	Tang YY, Hölzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci 2015;16:213-25.
33.	Cahn BR, Goodman MS, Peterson CT, Maturi R, Mills PJ. Yoga, Meditation and Mind-Body Health: Increased BDNF, Cortisol Awakening Response, and Altered Inflammatory Marker Expression after a 3-Month Yoga and Meditation Retreat. Front Hum Neurosci 2017;11:315.
34.	Pascoe MC, Thompson DR, Jenkins ZM, Ski CF. Mindfulness mediates the physiological markers of stress: Systematic review and meta-analysis. J Psychiatr Res 2017;95:156-78.
35.	Brown LF, Kroenke K, Theobald DE, Wu J, Tu W. The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psycho-Oncology 2010;19:734-41.

Advanced Biomedical Research